Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Zenas BioPharma, Inc. | 400,000 | reported | 15 Apr 2025 | tx 1+400,000 |
| Tvardi Therapeutics, Inc. | 195,000 | reported | 04 Jun 2024 | tx 5+468,811 |
| Seres Therapeutics, Inc. | 39,875 | reported | 18 Feb 2025 | tx 33+2,027,415−80,417 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Apr 2025 | GRANT_AWARD | Zenas BioPharma, Inc. | 400,000 | 0.00 USD | deriv |
| 15 Feb 2025 | EXERCISE | Seres Therapeutics, Inc. | 8,907 | — | |
| 15 Feb 2025 | EXERCISE | Seres Therapeutics, Inc. | 2,969 | — | |
| 18 Feb 2025 | SALE | Seres Therapeutics, Inc. | 4,416 | 0.81 USD | |
| 15 Feb 2025 | EXERCISE | Seres Therapeutics, Inc. | 2,969 | 0.00 USD | deriv |
| 15 Feb 2025 | EXERCISE | Seres Therapeutics, Inc. | 8,907 | 0.00 USD | deriv |
| 07 Feb 2025 | GRANT_AWARD | Seres Therapeutics, Inc. | 650,000 | 0.00 USD | deriv |
| 15 Nov 2024 | EXERCISE | Seres Therapeutics, Inc. | 2,969 | — | |
| 18 Nov 2024 | SALE | Seres Therapeutics, Inc. | 977 | 0.54 USD | |
| 15 Nov 2024 | EXERCISE | Seres Therapeutics, Inc. | 2,969 | 0.00 USD | deriv |
| 28 Oct 2024 | SALE | Seres Therapeutics, Inc. | 4,334 | 0.69 USD | |
| 27 Oct 2024 | EXERCISE | Seres Therapeutics, Inc. | 13,744 | 0.00 USD | |
| 27 Oct 2024 | EXERCISE | Seres Therapeutics, Inc. | 13,744 | 0.00 USD | deriv |
| 15 Aug 2024 | EXERCISE | Seres Therapeutics, Inc. | 2,969 | — | |
| 16 Aug 2024 | SALE | Seres Therapeutics, Inc. | 973 | 0.84 USD | |
| 15 Aug 2024 | EXERCISE | Seres Therapeutics, Inc. | 2,969 | 0.00 USD | deriv |
| 04 Jun 2024 | GRANT_AWARD | Tvardi Therapeutics, Inc. | 150,647 | 0.00 USD | |
| 04 Jun 2024 | GRANT_AWARD | Tvardi Therapeutics, Inc. | 195,000 | 0.00 USD | deriv |
| 15 May 2024 | SALE | Seres Therapeutics, Inc. | 939 | 0.94 USD | |
| 15 May 2024 | EXERCISE | Seres Therapeutics, Inc. | 2,968 | — | |
| 15 May 2024 | EXERCISE | Seres Therapeutics, Inc. | 2,968 | 0.00 USD | deriv |
| 15 Feb 2024 | EXERCISE | Seres Therapeutics, Inc. | 11,875 | — | |
| 16 Feb 2024 | SALE | Seres Therapeutics, Inc. | 4,400 | 1.08 USD | |
| 15 Feb 2024 | EXERCISE | Seres Therapeutics, Inc. | 11,875 | 0.00 USD | deriv |
| 14 Feb 2024 | GRANT_AWARD | Seres Therapeutics, Inc. | 287,905 | 0.00 USD | deriv |